Antithrombin Replacement in Cardiac Surgery: Was Too Much of a Good Thing Bad?

[1]  M. Ranucci,et al.  The Rise and Fall of Antithrombin Supplementation in Cardiac Surgery , 2022, Anesthesia and analgesia.

[2]  B. Spiess,et al.  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Antithrombin Supplementation in Patients at Risk for Antithrombin Deficiency After Cardiac Surgery , 2022, Anesthesia and analgesia.

[3]  A. Rezaie,et al.  Antithrombin: An anticoagulant, anti‐inflammatory and antibacterial serpin , 2020, Journal of thrombosis and haemostasis : JTH.

[4]  S. Senn,et al.  Treatment Effects in Multicenter Randomized Clinical Trials , 2019, JAMA.

[5]  S. Bagshaw,et al.  Restrictive or Liberal Red‐Cell Transfusion for Cardiac Surgery , 2017, The New England journal of medicine.

[6]  Mingyu Liang,et al.  Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury , 2017, Journal of cellular and molecular medicine.

[7]  Mingyu Liang,et al.  Antithrombin III Protects Against Contrast-Induced Nephropathy , 2017, EBioMedicine.

[8]  T. Fiore,et al.  Antithrombin administration in patients with low antithrombin values after cardiac surgery: a randomized controlled trial. , 2014, The Annals of thoracic surgery.

[9]  G. Pelissero,et al.  Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial. , 2013, The Journal of thoracic and cardiovascular surgery.

[10]  A. Cardona,et al.  Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. , 2012, The Cochrane database of systematic reviews.

[11]  S. Aranki,et al.  Postoperative Activity, but Not Preoperative Activity, of Antithrombin Is Associated with Major Adverse Cardiac Events After Coronary Artery Bypass Graft Surgery , 2009, Anesthesia and analgesia.

[12]  M. F. Ibrahim,et al.  Antithrombin after cardiac surgery: implications on short and mid-term outcome , 2007, Journal of Thrombosis and Thrombolysis.

[13]  S. Opal,et al.  Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation , 2006, Journal of thrombosis and haemostasis : JTH.

[14]  L. Menicanti,et al.  Postoperative antithrombin levels and outcome in cardiac operations , 2005, Critical care medicine.

[15]  S. Opal,et al.  High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial , 2001 .